ABNOM
☆ V rezultatih raziskave Stiftung Warentest iz Nemčije leta 2022 je bilo zadovoljstvo potrošnikov z ModelDermom le nekoliko nižje kot s plačanimi telemedicinskimi svetovanji.
References
Znano je, da Q-switched Nd:YAG laser učinkovito zdravi nevus Ota in podobna stanja. Izvedli smo študijo, da bi ugotovili, kako dobro high-fluence 1064 nm Q-switched Nd:YAG laser deluje na mongolske lise na nenavadnih območjih, ne da bi povzročil posvetlitev kože. Preučevali smo 61 bolnikov s temi pikami in pregledali skupno 70 lezij. Polovica lezij je bila zdravljena z laserjem, druge pa za primerjavo niso bile zdravljene. Rezultate smo ovrednotili s tehtnico in napravo, imenovano Mexameter® za merjenje ravni melanina. Bolnike so spremljali povprečno 14 mesecev v zdravljeni skupini in 18 mesecev v opazovani skupini. Na koncu študije smo ugotovili pomembne razlike v rezultatih na lestvici in ravni melanina med zdravljenimi in nezdravljenimi skupinami, pri čemer je lasersko zdravljena skupina pokazala boljše rezultate. High-fluence Q-switched Nd:YAG laser se je izkazal za učinkovitega in varnega za zdravljenje teh nenavadnih mongolskih madežev, ne da bi povzročil posvetlitev kože.
The Q-switched Nd:YAG laser is known to effectively treat nevus of Ota and similar conditions. We conducted a study to see how well a high-fluence 1064 nm Q-switched Nd:YAG laser worked on Mongolian spots in unusual areas, without causing the skin to lighten. We studied 61 patients with these spots, examining a total of 70 lesions. Half of lesions were treated with the laser, while others were left untreated for comparison. We evaluated the results using a scale and a device called a Mexameter® to measure melanin levels. Patients were followed up for an average of 14 months in the treatment group and 18 months in the observation group. At the end of the study, we found significant differences in the scale scores and melanin levels between the treated and untreated groups, with the laser-treated group showing better outcomes. The high-fluence Q-switched Nd:YAG laser, without causing skin lightening, proved effective and safe for treating these unusual Mongolian spots.
The Q-switched Nd:YAG laser is known to effectively treat nevus of Ota and similar conditions. We conducted a study to see how well a high-fluence 1064 nm Q-switched Nd:YAG laser worked on Mongolian spots in unusual areas, without causing the skin to lighten. We studied 61 patients with these spots, examining a total of 70 lesions. Half of lesions were treated with the laser, while others were left untreated for comparison. We evaluated the results using a scale and a device called a Mexameter® to measure melanin levels. Patients were followed up for an average of 14 months in the treatment group and 18 months in the observation group. At the end of the study, we found significant differences in the scale scores and melanin levels between the treated and untreated groups, with the laser-treated group showing better outcomes. The high-fluence Q-switched Nd:YAG laser, without causing skin lightening, proved effective and safe for treating these unusual Mongolian spots.
Preučevali smo učinkovitost in varnost uporabe določenega laserskega zdravljenja za ABNOM in preučili, kateri dejavniki lahko vplivajo na to, kako dobro deluje. Pregledali smo 110 bolnikov, ki so imeli ABNOM in so prejeli od dva do devet laserskih zdravljenj. Ugotovili smo, da je zdravljenje delovalo bolje, ko je trajalo dlje, vendar ne tako dobro pri starejših bolnikih. Bolje je deloval tudi pri bolnikih s svetlejšo kožo (tip III) in manjšimi prizadetimi predeli (manj kot 10 cm2) . Zaradi melazme skupaj z ABNOM je bilo zdravljenje manj učinkovito. Zdi se, da barva ali število prizadetih območij nista vplivala. Približno 10 % bolnikov je po zdravljenju dobilo temnejše lise. Zgodnje večkratno zdravljenje je dalo dobre rezultate. Starejši bolniki s temnejšo kožo in temnejšimi madeži imajo večjo verjetnost, da bodo po zdravljenju dobili temnejše madeže. Za bolnike z ABNOM in melazmo je bolje uporabiti laser z manjšo energijo, da preprečite poslabšanje melazme.
To evaluate the efficacy and safety of 1064-nm Q-switched Nd:YAG laser (QSNYL) therapy for ABNOM and to identify the factors influencing the outcome. A total of 110 patients with ABNOM were retrospectively evaluated and received two-to-nine treatment sessions. The curative effect was positively correlated with the treatment time and negatively correlated with the increasing age at first treatment (p < 0.05). The curative effect was better in patients with skin type III than those with type IV ( p < 0.05) and in patients with a lesion area of less than 10 cm2 than those with a larger affected area (p < 0.05). Additionally, the treatment effect was poorer in patients with concomitant melasma (p < 0.05). The treatment effect was not significantly correlated with the lesion color or number of affected sites (p > 0.05). Eleven patients (10%) developed postinflammatory hyperpigmentation (PIH). Early and repeated QSNYL therapy achieved satisfactory results for ABNOM. The risk of PIH after laser treatment is highest among patients with older age, darker lesion color, and darker skin color. For patients with ABNOM with concurrent melasma, low-energy laser therapy is recommended to reduce the risk of melasma aggravation.
To evaluate the efficacy and safety of 1064-nm Q-switched Nd:YAG laser (QSNYL) therapy for ABNOM and to identify the factors influencing the outcome. A total of 110 patients with ABNOM were retrospectively evaluated and received two-to-nine treatment sessions. The curative effect was positively correlated with the treatment time and negatively correlated with the increasing age at first treatment (p < 0.05). The curative effect was better in patients with skin type III than those with type IV ( p < 0.05) and in patients with a lesion area of less than 10 cm2 than those with a larger affected area (p < 0.05). Additionally, the treatment effect was poorer in patients with concomitant melasma (p < 0.05). The treatment effect was not significantly correlated with the lesion color or number of affected sites (p > 0.05). Eleven patients (10%) developed postinflammatory hyperpigmentation (PIH). Early and repeated QSNYL therapy achieved satisfactory results for ABNOM. The risk of PIH after laser treatment is highest among patients with older age, darker lesion color, and darker skin color. For patients with ABNOM with concurrent melasma, low-energy laser therapy is recommended to reduce the risk of melasma aggravation.
○ Zdravljenje
Belilna sredstva redkokdaj pomagajo. Za razliko od melazme je mogoče ABNOM izboljšati z laserskim zdravljenjem in pustiti, da se odstrani brez ponovitve. Lasersko zdravljenje se lahko izvede 10- do 20-krat za zdravljenje ABNOM.
#QS1064 laser